Osteoarthritis Trial, Recruiting NCT06173713 Sponsor: Canadian Radiostereometric Analysis Network Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT06173713
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who need their first total hip replacement due to severe hip pain or disability caused by osteoarthritis, rheumatoid arthritis, arthritis from an old injury, a hip joint that didn't form properly, bone death in the hip (AVN), or a recent hip fracture.
  • People who are able to read, understand, and sign a consent form agreeing to take part in the study and to share their information with the company running the trial (DePuy Synthes).
  • People who are willing and able to attend follow-up appointments as required by the study schedule.
  • People who are at least 21 years old at the time they sign the consent form.
  • People who are willing and able to fill out hip health questionnaires at the times specified by the study.

Who may not be able to join:

  • People who currently have an active infection anywhere in the body or at the hip site.
  • People whose muscles, nerves, or blood supply are affected in a way that could interfere with recovery after surgery.
  • People whose bones are too weak (for example, due to osteoporosis), where the surgeon believes the implant may not be properly supported or there is a significant risk of fracture.
  • People who have Charcot's disease or Paget's disease (conditions that affect bone structure).
  • People whose hip condition, in the surgeon's judgement, means the standard implant components used in this trial would not be appropriate for them.
  • Women who are pregnant or currently breastfeeding.
  • People who have had a hip replacement on the other side within the 6 months before joining this study, or who expect to have one on the other side within 6 months of joining.
  • People who have had an amputation of either leg that would affect their ability to recover after surgery.
  • People who are bedridden.
  • People who have taken part in another clinical trial involving an experimental drug or device within the last 3 months.
  • People who are currently involved in a personal injury lawsuit, medical-legal claim, or workers' compensation claim.
  • People who, in the investigator's opinion, have a drug or alcohol problem, or a psychological condition that could affect their ability to complete questionnaires or attend follow-up appointments.
  • People who have been diagnosed with a muscle disorder that causes severe stiffness and pain — such as fibromyalgia or polymyalgia — and are currently taking prescription medication for it.
  • People who have a medical condition that means they are not expected to live for at least another 2 years.
  • People with a body mass index (BMI) greater than 45 (confirm with trial site if unsure how this is calculated).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Thomas Turgeon, MD, Concordia Hospital

Phone: 204-926-1231

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Canadian Radiostereometric Analysis Network
Registry
ClinicalTrials.gov
Start date
11 February 2025
Est. completion
31 August 2027

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Migration - Shell; Migration - Stem

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov